News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Leslee J. Shaw, PhD

Articles by Leslee J. Shaw, PhD

Delivering Effective Lipid Management in the Managed Care Setting

ByLeslee J. Shaw, PhD

September 1st 2002

The HCA National Disease Management Program for Coronary Disease Detection and Treatment in Women

ByLeslee J. Shaw, PhD,Lynn Tarkington, BSN,Tracy Callister, MD,Joseph Murgo, MD,April Simon, BSN,Cynthia Waller, MSN,Sal Battaglia, BS

September 1st 2001

Hospital Resource Consumption in Patients with Diabetes and Multivessel Coronary Disease Undergoing Revascularization

BySteven D. Culler, PhD,William S. Weintraub, MD,Leslee J. Shaw, PhD,Edmund R. Becker, PhD

February 1st 2000

The Changing Healthcare Market and How It Has Influenced the Treatment of Cardiovascular Disease - Part I

ByEdmund R. Becker, PhD,Douglas C. Morris, MD,Steven D. Culler, PhD,Patrick D. Mauldin, PhD,Leslee J. Shaw, PhD,J. David Talley, MD,Will

September 1st 1999

The Changing Healthcare Market: Outlook for the Future of Cardiovascular Disease Treatment - Part II

ByEdmund R. Becker, PhD,Douglas C. Morris, MD,Steven D. Culler, PhD,Patrick D. Mauldin, PhD,Leslee J. Shaw, PhD,J. David Talley, MD,Will

September 1st 1999

Use of an Intravenous Contrast Agent (Optison) to Enhance Echocardiography: Efficacy and Cost Implications

ByLeslee J. Shaw, PhD,Linda Gillam, MD,Steven Feinstein, MD,John Dent, MD,Gary Plotnick, MD,for the Optison Multicenter Study Group

September 25th 1998

Cost Implications of Selective Preoperative Screening in the Care of Candidates for Peripheral Vascular Operations

ByLeslee J. Shaw, PhD,Rory Hachamovitch, MD,Mylan Cohen, MD,Daniel S. Berman, MD,Salvador Borges-Neto, MD,James E. Udelson, MD,Gary V. H

December 1st 1997

Latest Updated Articles

Cost Implications of Selective Preoperative Screening in the Care of Candidates for Peripheral Vascular Operations
December 1st 1997
Hospital Resource Consumption in Patients with Diabetes and Multivessel Coronary Disease Undergoing Revascularization
February 1st 2000
Use of an Intravenous Contrast Agent (Optison) to Enhance Echocardiography: Efficacy and Cost Implications
September 25th 1998
The Changing Healthcare Market and How It Has Influenced the Treatment of Cardiovascular Disease - Part I
September 1st 1999
The Changing Healthcare Market: Outlook for the Future of Cardiovascular Disease Treatment - Part II
September 1st 1999
The HCA National Disease Management Program for Coronary Disease Detection and Treatment in Women
September 1st 2001

Trending on AJMC

Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD

Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD

Counseling Vitiligo Patients on Time to Repigmentation

5 August FDA Approvals Marked by Novelty, Pushback

Cross-Trial Vitiligo Data: What Payers Can and Can't Compare